Brief: Vyant Bio Posts Q2 Revenue $1.9 Million
Aug 16 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS SECOND QUARTER 2021 RESULTS AND PROVIDES
STRATEGIC BUSINESS UPDATES
* Q2 REVENUE $1.9 MILLION
* CASH AND CASH EQUIVALENTS TOTALED $26.5 MILLION AS OF JUNE
30,
2021
* QTRLY LOSS PER SHARE $0.14
Source text for Eikon: ID:nGNX2NTD6n
Further company coverage: VYNT.O
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration